These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 149750)

  • 1. [Staphylococcal toxic epidermal necrolysis].
    Fritsch P
    Fortschr Med; 1978 Jul; 96(26-27):1361-5. PubMed ID: 149750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of cultured epidermis of human origin for demonstrating the acantholytic action of staphylococcal exfoliatin A].
    Gentilhomme E; Faure M; Arco A; Kanitakis J; Dumaine MH; Marmet D; Binder F; Fleurette J; Thivolet J
    Pathol Biol (Paris); 1988 Feb; 36(2):121-6. PubMed ID: 3279379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exfoliatin in neonatal staphylococcal infections].
    Willard D; Monteil H; Piemont Y; Assi R; Messer J; Lavillaureix J; Minck R; Gandar R
    Nouv Presse Med; 1982 Dec; 11(51):3769-71. PubMed ID: 7155881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on staphylococcal exfoliatin (author's transl)].
    Kondo I; Sakurai S
    Nihon Saikingaku Zasshi; 1979 Mar; 34(2):357-73. PubMed ID: 114684
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute skin disease due to staphylococcal infection (author's transl)].
    Peyramond D; Bensahkoun D; Bertrand JL
    Arch Fr Pediatr; 1980 Apr; 37(4):219-25. PubMed ID: 6447488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxic staphylococcal cutaneous necrolysis (scalded skin syndrome) (author's transl)].
    Larrègue M; Kalis B; Bressieux JM; Daniel J
    Ann Dermatol Venereol; 1977 Apr; 104(4):269-74. PubMed ID: 142436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Staphylococcal exfoliatin A and B (author's transl)].
    Kondo I
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():82-95. PubMed ID: 141057
    [No Abstract]   [Full Text] [Related]  

  • 8. Site of action of exfoliative toxin in the staphylococcal scaled-skin syndrome.
    Lillibridge CB; Melish ME; Glasgow LA
    Pediatrics; 1972 Nov; 50(5):728-38. PubMed ID: 4263751
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental models for studying the effects induced by staphylococcal toxins A and B on human keratinocytes in culture].
    Arco A; Faure M; Piemont Y; Thivolet J
    Arch Ital Anat Embriol; 1991; 96(3):185-99. PubMed ID: 1817457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice.
    Shibl AM
    Chemotherapy; 1981; 27(3):224-7. PubMed ID: 7226975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of exfoliatin producing Staphylococcus aureus isolated from various diseases (author's transl)].
    Futaki S; Hirayama K; Ichizawa Y; Hosoya R; Sarai Y
    Nihon Hifuka Gakkai Zasshi; 1977 Sep; 87(10):609-16. PubMed ID: 303712
    [No Abstract]   [Full Text] [Related]  

  • 12. Levels of exfoliatin antitoxin in pooled human serum globulin.
    Kapral FA
    J Infect Dis; 1979 Feb; 139(2):209-10. PubMed ID: 438533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal scalded skin syndrome I. Purification of exfoliatin and maternal transmission of neutralizing ability against exfoliatin.
    Nishioka K; Nakano T; Hirao N; Asada Y
    J Dermatol; 1977 Feb; 4(1):13-8. PubMed ID: 16688917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal toxic epidermal necrolysis: pathogenesis and studies on the subcellular site of action of exfoliatin.
    Elias PM; Fritsch P; Dahl MV; Wolff K
    J Invest Dermatol; 1975 Dec; 65(6):501-12. PubMed ID: 1194714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal toxic epidermal necrolysis: species and tissue susceptibility and resistance.
    Elias PM; Fritsch P; Mittermayer H
    J Invest Dermatol; 1976 Feb; 66(02):80-9. PubMed ID: 812924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals.
    Nishifuji K; Sugai M; Amagai M
    J Dermatol Sci; 2008 Jan; 49(1):21-31. PubMed ID: 17582744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible receptor substance for staphylococcal exfoliatin isolated from mice.
    Sakurai S; Kondo I
    Jpn J Med Sci Biol; 1979 Apr; 32(2):85-8. PubMed ID: 541875
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevalence of exfoliatin-producing strains in phage group II "Staphylococcus aureus" (author's transl)].
    Fleurette J; Ritter J
    Ann Microbiol (Paris); 1980; 131B(2):175-83. PubMed ID: 6450560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease.
    Kondo I; Sakurai S; Sarai Y
    Infect Immun; 1974 Oct; 10(4):851-61. PubMed ID: 4139120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical syndromes caused by staphylococcal epidermolytic toxin.
    Edlich RF; Horowitz JH; Nichter LS; Silloway KA; Morgan RF
    Compr Ther; 1985 Apr; 11(4):45-8. PubMed ID: 3159536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.